BioCentury
ARTICLE | Clinical News

MethylGene, Pharmion, Taiho preclinical data

April 21, 2008 7:00 AM UTC

In vitro, MGC0103 upregulated the N-myc downregulated gene 1 (NDRG1), which led to the differentiation of prostate cancer cells and decreased metastasis. MethylGene said NDRG1 is a prostate cancer met...